A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
for
Hormone Receptor Positive Early Breast Cancer
Location: Margate FL, Beverly Hills CA
Sponsor: Rovi Pharmaceuticals Laboratories
Sex: Female
Age: 18 - 70+
Code: NCT07401381
Phase1, Recruiting
A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.
for
Early Breast Cancer
Location: Dobbs Ferry NY, Los Angeles CA, Morgantown WV,
Sponsor: University College, London
Sex: Female
Age: 0+
Code: NCT01792726
Recruiting
Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy
for
Invasive Breast Cancer Early Stages,
Location: New York NY
Sponsor: HeroSupport SA
Sex: Female
Age: 40+
Code: NCT07711847
Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for
Early Breast Cancer
Location: Boston MA, Providence RI, Lake Success NY, Jamaica NY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT05827081
Phase3, Recruiting
National Mammography Database
for
Breast Cancer Screening and Diagnosis
Location: Reston VA
Sponsor: American College of Radiology
Sex: All
Age: 2 - 70+
Code: NCT01900821
Recruiting
Interested in new breast cancer, early breast cancer trials?
Get alerts for new trials in your area by subscribing now
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: South Weymouth MA, Danvers MA, Waltham MA, Boston MA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
for
Breast Cancer, Breast Neoplasms, Breast Cancers
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT06517212
Phase2, Recruiting
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
for
Breast Neoplasms
Location: Shirley NY, Indianapolis IN, Nashville TN, Houston TX
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07287098
Phase2, Recruiting
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
for
Breast Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT06106477
Recruiting
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
for
Breast Cancer, DCIS, LCIS
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: Female
Age: 40+
Code: NCT03936478
Phase2, Recruiting
APBI: 27Gy in 5 Fractions for Early Breast Cancer
for
Breast Cancer
Location: Calgary
Sponsor: AHS Cancer Control Alberta
Sex: Female
Age: 50+
Code: NCT02681107
Recruiting
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
for
Breast Cancer, Breast Neoplasm, Breast Cancer Female,
Location: Houston TX
Sponsor: Baylor Breast Care Center
Sex: All
Age: 18+
Code: NCT05020860
Phase2, Recruiting
New
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
for
Low-Risk, Early Stage Breast Cancer
Location: Germantown TN, Glendale CA
Sponsor: IceCure Medical Ltd.
Sex: All
Age: 70+
Code: NCT07629206
Recruiting
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
for
Early Stage Breast Cancer
Location: Hartford CT, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 21 - 70+
Code: NCT04458532
Recruiting
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
for
Cardiac Toxicity, Early-stage Breast Cancer
Location: Long Branch NJ, Jersey City NJ, Lakewood NJ,
Sponsor: Rutgers, The State University of New Jersey
Sex: Female
Age: 18+
Code: NCT05559164
Phase2, Recruiting
Cardiometabolic Screening Program
for
Breast Cancer, Early-stage Breast Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT05386719
Recruiting
Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy
for
Early-stage Breast Cancer
Location: Ottawa, Kingston, Oshawa
Sponsor: Ottawa Hospital Research Institute
Sex: All
Age: 18+
Code: NCT05753618
Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: New Haven CT, The Bronx NY, New York NY,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All
Age: 18+
Code: NCT01042379
Phase2, Recruiting
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
for
Breast Cancer, Early-stage Breast Cancer
Location: Washington D.C. DC
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Female
Age: 18+
Code: NCT06536881
Recruiting
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
for
Breast Cancer Invasive, Early-stage Breast Cancer,